Synergistic Potential of Herbal Polytherapy in Benign Prostatic Hyperplasia: An Integrative Phytomedicine Perspective
Abstract
Benign prostatic hyperplasia (BPH) is a prevalent age-related urological disorder associated with progressive prostate gland enlargement and lower urinary tract symptoms (LUTS). While conventional therapies such as alpha-blockers and 5-alpha reductase inhibitors offer symptom relief, they are often accompanied by adverse effects and limited long-term efficacy. Increasingly, interest is growing in phytotherapeutic approaches that harness the therapeutic synergy of multiple herbal compounds. Herbal polytherapy, the use of combinations of medicinal plants, is rooted in traditional medicine systems and increasingly supported by experimental evidence. This review explores the integrative phytomedicine perspective of herbal polytherapy in BPH management, emphasizing the mechanistic rationale for combining herbs, their multi-targeted effects on inflammation, oxidative stress, hormonal modulation, apoptosis, and smooth muscle relaxation. Notable herbal combinations, including Serenoa repens, Pygeum africanum, Urtica dioica, Curcuma longa, and Camellia sinensis, are examined for their synergistic interactions and evidence of clinical efficacy. The pharmacokinetic and safety challenges of polyherbal formulations are discussed alongside emerging nanotechnological strategies to enhance bioavailability. The review advocates for standardized, evidence-based integration of herbal polytherapy into BPH treatment regimens and calls for rigorously designed clinical trials to establish…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.